We are live on ! Find out more
IBIO icon

iBio
IBIO

Fund managers haven’t disclosed any holdings of IBIO yet.

IBIO Hedge Fund Activity: Q1 2026 in Review

52 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q1 2026, worth a combined $36.9M — up 17% from $31.6M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new IBIO positions and 12 closed out — a net gain of 4 holders — while 16 added to existing stakes and 8 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $3.6M. The largest seller was Logos Global Management, cutting an estimated $1.62M.

  • 52 institutional investors held iBio (IBIO) as of Q1 2026, up from 50 in Q4 2025.
  • Funds reported $36.9M of iBio stock for Q1 2026, up 17% quarter-over-quarter.
  • 16 funds opened new iBio positions in Q1 2026 and 12 closed out, a net change of +4 holders.
  • The largest iBio buyer in Q1 2026 was Millennium Management, an estimated $3.6M added.
  • The largest iBio seller in Q1 2026 was Logos Global Management, an estimated $1.62M sold.

Based on aggregated 13F filings for Q1 2026.